Pfizer Pills: Urgent License Application Coming Soon – Will Change Game Terms |

by

“Today is a day of pride for Pfizer,” said Albert Burla, president and CEO of the pharmaceutical industry, following the encouraging results of Pfizer’s coronavirus pill. Reduces the risk of hospitalization and death by 89% in high-risk groups.

Mr. Bourla emphasizes that today clearly shows the power of science and scientists to quickly develop a good that will benefit all of humanity.

The head of the pharmaceutical industry reports that the results of the phase 2 mid-term study showed that the candidate antiviral drug given in combination with a low dose of ritonavir reduces by 89% the risk of coronavirus hospitalization or death in high-risk non-high-risk adults.

Mr. Bourla emphasizes that if the preparation is approved by the competent authorities, it seems that it has the conditions to change the terms of the game, saving human lives, reducing the severity of COVID-19 disease and eliminating up to nine out of ten treatments.

It is noted that, as he said in an interview with CNBC, Pfizer is going to submit the data of the investigation to the FDA, in order to receive approval, before November 25, ie this year’s Thanksgiving in the US.

.

You May Also Like

Recommended for you